source
- Scancell to merge into Neuphoria and seek $89 million equity as AstraZeneca's breast cancer drug gains EU approvalScancell announced it will merge into Neuphoria Therapeutics, taking over Neuphoria's Nasdaq listing ($NEUP) and planning to change the ticker to SCLT. The combined entity aims to raise up to $89 m…
- Senate health committee delays vote on Trump nominee for ASPR amid anti-vaccine controversyThe Senate health committee postponed its vote on Sean Kaufman, the Trump administration’s pick to lead the Office of the Assistant Secretary for Preparedness and Response (ASPR). The delay came ju…